CNTN Stock Summary and Trading Ideas (Canton Strategic Holdings | NASDAQ:CNTN)

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Canton Strategic Holdings trades on the NASDAQ stock market under the symbol CNTN.

As of June 18, 2026, CNTN stock price declined to $3.35 with 2,404,145 million shares trading.

CNTN has a beta of 2.77, meaning it tends to be more sensitive to market movements. CNTN has a correlation of 0.17 to the broad based SPY ETF.

CNTN has a market cap of $233.85 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that CNTN belongs to (by Net Assets): ARKF, VXF, NODE, AVSC, BCDF.

CNTN support price is $3.27 and resistance is $3.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNTN shares will trade within this expected range on the day.